buserelin acetate
intervet australia pty limited - buserelin acetate - unknown - buserelin acetate hormone-gonadotrophin active 0.0 - active constituent
suprefact depot 3-months
sanofi - aventis israel ltd - buserelin acetate - rods for implant - buserelin acetate 9.9 mg - buserelin - buserelin - treatment of advanced hormone dependent prostatic carcinoma. however not after bilateral orchiectomy ( no further reduction of testosterone level by buserelin to be expected).
buserelin acetate powder
ax pharmaceutical corp - buserelin acetate (unii: 13u86g7ysp) (buserelin acetate - unii:13u86g7ysp) -
suprefact buserelin acetate 1.05 mg/ml solution for injection vial
sanofi-aventis australia pty ltd - buserelin acetate -
suprefact depot 2 months implant
cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - implant - 6.3mg - buserelin (buserelin acetate) 6.3mg - antineoplastic agents
suprefact depot 3 months implant
cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - implant - 9.45mg - buserelin (buserelin acetate) 9.45mg - antineoplastic agents
buserelin acetate
intervet australia pty limited - buserelin acetate - unknown - buserelin acetate hormone-gonadotrophin active 0.0 - active constituent
ax pharmaceutical- buserelin acetate powder
ax pharmaceutical corp - buserelin acetate (unii: 13u86g7ysp) (buserelin - unii:pxw8u3yxdv) - buserelin .99 g in 1 g
buserelin acetate nasal solution 0.15% "f" [for endometriosis and uterine fibroid] (ブセレリン点鼻液0.15%「f」[子宮内膜症・子宮筋腫])
fuji pharmaceutical co.,ltd. - buserelin acetate - limpid and colorless nasal solution
suprefact solution
cheplapharm arzneimittel gmbh - buserelin (buserelin acetate) - solution - 100mcg - buserelin (buserelin acetate) 100mcg - antineoplastic agents